PT2788009T - Células pulmonares fetais de mamíferos e uso terapêutico das mesmas - Google Patents

Células pulmonares fetais de mamíferos e uso terapêutico das mesmas

Info

Publication number: PT2788009T
Authority: PT; Portugal
Prior art keywords: same; therapeutic use; pulmonary cells; mammalian fetal; fetal pulmonary
Prior art date: 2011-12-08

Application number

PT128139904T

Other languages

English (en)

Inventor

Reisner Yair

Shezen Elias

Rosen Chava

Original Assignee

Yeda Res & Dev

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2011-12-08

Filing date

2012-12-06

Publication date

2016-08-31

2012-12-06 Application filed by Yeda Res & Dev filed Critical Yeda Res & Dev

2016-08-31 Publication of PT2788009T publication Critical patent/PT2788009T/pt

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/48—Reproductive organs
- A61K35/54—Ovaries; Ova; Ovules; Embryos; Foetal cells; Germ cells
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/42—Respiratory system, e.g. lungs, bronchi or lung cells
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0688—Cells from the lungs or the respiratory tract

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
General Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Biomedical Technology (AREA)
Cell Biology (AREA)
Zoology (AREA)
Biotechnology (AREA)
Immunology (AREA)
Pulmonology (AREA)
Neurology (AREA)
Developmental Biology & Embryology (AREA)
Genetics & Genomics (AREA)
Wood Science & Technology (AREA)
Diabetes (AREA)
Epidemiology (AREA)
Virology (AREA)
Neurosurgery (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Reproductive Health (AREA)
Biochemistry (AREA)
Physiology (AREA)
Microbiology (AREA)
General Engineering & Computer Science (AREA)
Physical Education & Sports Medicine (AREA)
Orthopedic Medicine & Surgery (AREA)
Urology & Nephrology (AREA)
Hematology (AREA)

PT128139904T 2011-12-08 2012-12-06 Células pulmonares fetais de mamíferos e uso terapêutico das mesmas PT2788009T (pt)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US201161568240P	2011-12-08	2011-12-08

Publications (1)

Publication Number	Publication Date
PT2788009T true PT2788009T (pt)	2016-08-31

Family

ID=47557423

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PT128139904T PT2788009T (pt)	2011-12-08	2012-12-06	Células pulmonares fetais de mamíferos e uso terapêutico das mesmas

Country Status (19)

Country	Link
US (1)	US9833482B2 (pt)
EP (2)	EP2788009B1 (pt)
JP (1)	JP2015500279A (pt)
KR (1)	KR20140102730A (pt)
CN (1)	CN104105493A (pt)
AU (1)	AU2012348574A1 (pt)
CA (1)	CA2857930A1 (pt)
ES (2)	ES2673471T3 (pt)
HK (1)	HK1202809A1 (pt)
HU (1)	HUE030541T2 (pt)
IL (1)	IL233022A (pt)
MX (1)	MX2014006756A (pt)
PH (1)	PH12014501309A1 (pt)
PL (1)	PL2788009T3 (pt)
PT (1)	PT2788009T (pt)
RU (1)	RU2014127338A (pt)
SG (1)	SG11201402902VA (pt)
WO (1)	WO2013084190A1 (pt)
ZA (1)	ZA201404958B (pt)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP6196620B2 (ja)	2011-09-08	2017-09-13	イェダリサーチアンドデベロップメントカンパニーリミテッド	抗第三者セントラルメモリーｔ細胞、その作製方法ならびに移植および疾患処置におけるその使用
AU2012348574A1 (en)	2011-12-08	2014-07-24	Yeda Research And Development Co. Ltd.	Mammalian fetal pulmonary cells and therapeutic use of same
CN104977414B (zh) *	2014-04-09	2016-09-28	上海交通大学医学院	鉴定骨髓中是否存在保护白血病干细胞微环境的试剂盒及其应用
EP4026563A1 (en)	2015-06-18	2022-07-13	Yeda Research and Development Co. Ltd	Conditioning protocols and use of same for tissue regeneration
ES2946785T3 (es) *	2015-07-16	2023-07-26	Yeda Res & Dev	Linfocitos T de memoria central anti-terceros modificados genéticamente y uso de los mismos en inmunoterapia
WO2017203520A1 (en)	2016-05-22	2017-11-30	Yeda Research And Development Co. Ltd.	Methods of using pulmonary cells for transplantation and induction of tolerance
US10751368B2 (en)	2017-01-18	2020-08-25	Yeda Research And Development Co. Ltd.	Methods of transplantation and disease treatment
WO2018134824A1 (en)	2017-01-18	2018-07-26	Yeda Research And Development Co. Ltd.	Genetically modified veto cells and use of same in immunotherapy
EP3704225B1 (en) *	2017-10-27	2023-10-11	Alis Pharma Ltd.	Fetal tissue extract, methods for producing the extract, and the use thereof
CN109529123B (zh) *	2018-11-08	2021-02-19	中国人民解放军第四军医大学	水凝胶、纳米纤维支架与皮肤细胞层层组装的血管化全层组织工程皮肤及其制备方法
EP3747992A1 (en)	2019-06-04	2020-12-09	Medizinische Hochschule Hannover	Compositions and process for integrating cells into epithelium
CN111518761B (zh) *	2020-05-25	2022-04-29	青岛瑞思德生物科技有限公司	一种间充质干细胞体外筛选、激活、扩增、冻存及其细胞库建立的方法
WO2023105526A1 (en)	2021-12-08	2023-06-15	Yeda Research And Development Co. Ltd.	Multipotent lung progenitor cells for lung regeneration

Family Cites Families (41)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
NL154600B (nl)	1971-02-10	1977-09-15	Organon Nv	Werkwijze voor het aantonen en bepalen van specifiek bindende eiwitten en hun corresponderende bindbare stoffen.
NL154598B (nl)	1970-11-10	1977-09-15	Organon Nv	Werkwijze voor het aantonen en bepalen van laagmoleculire verbindingen en van eiwitten die deze verbindingen specifiek kunnen binden, alsmede testverpakking.
NL154599B (nl)	1970-12-28	1977-09-15	Organon Nv	Werkwijze voor het aantonen en bepalen van specifiek bindende eiwitten en hun corresponderende bindbare stoffen, alsmede testverpakking.
US3901654A (en)	1971-06-21	1975-08-26	Biological Developments	Receptor assays of biologically active compounds employing biologically specific receptors
US3853987A (en)	1971-09-01	1974-12-10	W Dreyer	Immunological reagent and radioimmuno assay
US3867517A (en)	1971-12-21	1975-02-18	Abbott Lab	Direct radioimmunoassay for antigens and their antibodies
NL171930C (nl)	1972-05-11	1983-06-01	Akzo Nv	Werkwijze voor het aantonen en bepalen van haptenen, alsmede testverpakkingen.
US3850578A (en)	1973-03-12	1974-11-26	H Mcconnell	Process for assaying for biologically active molecules
US3935074A (en)	1973-12-17	1976-01-27	Syva Company	Antibody steric hindrance immunoassay with two antibodies
US3996345A (en)	1974-08-12	1976-12-07	Syva Company	Fluorescence quenching with immunological pairs in immunoassays
US4034074A (en)	1974-09-19	1977-07-05	The Board Of Trustees Of Leland Stanford Junior University	Universal reagent 2-site immunoradiometric assay using labelled anti (IgG)
US3984533A (en)	1975-11-13	1976-10-05	General Electric Company	Electrophoretic method of detecting antigen-antibody reaction
US4098876A (en)	1976-10-26	1978-07-04	Corning Glass Works	Reverse sandwich immunoassay
US4879219A (en)	1980-09-19	1989-11-07	General Hospital Corporation	Immunoassay utilizing monoclonal high affinity IgM antibodies
US5011771A (en)	1984-04-12	1991-04-30	The General Hospital Corporation	Multiepitopic immunometric assay
US4666828A (en)	1984-08-15	1987-05-19	The General Hospital Corporation	Test for Huntington's disease
US4683202A (en)	1985-03-28	1987-07-28	Cetus Corporation	Process for amplifying nucleic acid sequences
US4801531A (en)	1985-04-17	1989-01-31	Biotechnology Research Partners, Ltd.	Apo AI/CIII genomic polymorphisms predictive of atherosclerosis
US5004681B1 (en)	1987-11-12	2000-04-11	Biocyte Corp	Preservation of fetal and neonatal hematopoietic stem and progenitor cells of the blood
US5192553A (en)	1987-11-12	1993-03-09	Biocyte Corporation	Isolation and preservation of fetal and neonatal hematopoietic stem and progenitor cells of the blood and methods of therapeutic use
US5272057A (en)	1988-10-14	1993-12-21	Georgetown University	Method of detecting a predisposition to cancer by the use of restriction fragment length polymorphism of the gene for human poly (ADP-ribose) polymerase
US5192659A (en)	1989-08-25	1993-03-09	Genetype Ag	Intron sequence analysis method for detection of adjacent and remote locus alleles as haplotypes
US5281521A (en)	1992-07-20	1994-01-25	The Trustees Of The University Of Pennsylvania	Modified avidin-biotin technique
US5656498A (en)	1994-02-22	1997-08-12	Nippon Telegraph And Telephone Corporation	Freeze-dried blood cells, stem cells and platelets, and manufacturing method for the same
US6204053B1 (en)	1994-11-08	2001-03-20	Diacrin, Inc.	Porcine cortical cells and their use in treatment of neurological deficits due to neurodegenerative diseases
US6110459A (en)	1997-05-28	2000-08-29	Mickle; Donald A. G.	Transplants for myocardial scars and methods and cellular preparations
US5955257A (en)	1997-10-21	1999-09-21	Regents Of The University Of Minnesota	Infusible grade short-term cell storage medium for mononuclear cells
US8609412B2 (en) *	1999-08-05	2013-12-17	Regents Of The University Of Minnesota	Mapc generation of lung tissue
EP1099754A1 (en) *	1999-11-10	2001-05-16	Universiteit Leiden	Mesenchymal stem cells and/or progenitor cells, their isolation and use
US20030096016A1 (en) *	2001-09-07	2003-05-22	Yeda Research And Development Co. Ltd.	Methods of kidney transplantation utilizing developing nephric tissue
US20040136972A1 (en)	2001-09-07	2004-07-15	Yeda Research And Development Co. Ltd.	Methods of treating disease by transplantation of developing allogeneic or xenogeneic organs or tissues
US20030215942A1 (en)	2002-02-14	2003-11-20	Stemcyte, Inc.	Undesignated allogeneic stem cell bank
IL164048A0 (en)	2002-03-15	2005-12-18	Univ North Carolina	Primitive and proximal hepatic stemcells
GB0304799D0 (en)	2003-03-03	2003-04-09	Glaxosmithkline Biolog Sa	Novel method
WO2006038211A2 (en) *	2004-10-04	2006-04-13	Yeda Research And Development Co. Ltd.	Disease treatment via developing non-syngeneic graft transplantation
US8628964B2 (en) *	2006-10-11	2014-01-14	Drexel University	Fetal pulmonary cells and uses thereof
US20100034791A1 (en)	2007-02-14	2010-02-11	Drexel University	Engineered Lung Tissue Construction for High Throughput Toxicity Screening and Drug Discovery
US9534204B2 (en) *	2010-10-05	2017-01-03	Aal Scientifics, Inc.	Human lung stem cells and uses thereof
AU2012348574A1 (en)	2011-12-08	2014-07-24	Yeda Research And Development Co. Ltd.	Mammalian fetal pulmonary cells and therapeutic use of same
SG10201801905WA (en)	2011-12-22	2018-04-27	Yeda Res & Dev	A combination therapy for a stable and long term engraftment
EP4026563A1 (en)	2015-06-18	2022-07-13	Yeda Research and Development Co. Ltd	Conditioning protocols and use of same for tissue regeneration

2012
- 2012-12-06 AU AU2012348574A patent/AU2012348574A1/en not_active Abandoned
- 2012-12-06 PT PT128139904T patent/PT2788009T/pt unknown
- 2012-12-06 CN CN201280069291.9A patent/CN104105493A/zh active Pending
- 2012-12-06 JP JP2014545442A patent/JP2015500279A/ja active Pending
- 2012-12-06 CA CA2857930A patent/CA2857930A1/en not_active Abandoned
- 2012-12-06 ES ES16151376.7T patent/ES2673471T3/es active Active
- 2012-12-06 MX MX2014006756A patent/MX2014006756A/es unknown
- 2012-12-06 HK HK15103466.2A patent/HK1202809A1/xx unknown
- 2012-12-06 WO PCT/IB2012/057042 patent/WO2013084190A1/en active Application Filing
- 2012-12-06 EP EP12813990.4A patent/EP2788009B1/en active Active
- 2012-12-06 PL PL12813990.4T patent/PL2788009T3/pl unknown
- 2012-12-06 RU RU2014127338A patent/RU2014127338A/ru not_active Application Discontinuation
- 2012-12-06 US US14/363,814 patent/US9833482B2/en active Active
- 2012-12-06 EP EP16151376.7A patent/EP3034087B1/en active Active
- 2012-12-06 ES ES12813990.4T patent/ES2587876T3/es active Active
- 2012-12-06 HU HUE12813990A patent/HUE030541T2/en unknown
- 2012-12-06 KR KR1020147018702A patent/KR20140102730A/ko not_active Withdrawn
- 2012-12-06 SG SG11201402902VA patent/SG11201402902VA/en unknown
2014
- 2014-06-08 IL IL233022A patent/IL233022A/en active IP Right Grant
- 2014-06-09 PH PH12014501309A patent/PH12014501309A1/en unknown
- 2014-07-07 ZA ZA2014/04958A patent/ZA201404958B/en unknown

Also Published As

Publication number	Publication date
ES2587876T3 (es)	2016-10-27
EP2788009B1 (en)	2016-05-25
HK1202809A1 (en)	2015-10-09
MX2014006756A (es)	2015-03-09
ZA201404958B (en)	2015-05-27
EP3034087B1 (en)	2018-03-14
AU2012348574A1 (en)	2014-07-24
ES2673471T3 (es)	2018-06-22
IL233022A0 (en)	2014-07-31
PL2788009T3 (pl)	2016-11-30
EP2788009A1 (en)	2014-10-15
RU2014127338A (ru)	2016-02-10
US20140356335A1 (en)	2014-12-04
IL233022A (en)	2017-12-31
JP2015500279A (ja)	2015-01-05
CA2857930A1 (en)	2013-06-13
PH12014501309A1 (en)	2014-09-15
KR20140102730A (ko)	2014-08-22
US9833482B2 (en)	2017-12-05
WO2013084190A1 (en)	2013-06-13
NZ627071A (en)	2015-11-27
CN104105493A (zh)	2014-10-15
HUE030541T2 (en)	2017-05-29
EP3034087A1 (en)	2016-06-22
SG11201402902VA (en)	2014-07-30

Publication	Publication Date	Title
ZA201404958B (en)	2015-05-27	Mammalian fetal pulmonary cells and therapeutic use of same
SG11201402194RA (en)	2014-09-26	Cd40l expressing mammalian cells and their use
SI2683815T1 (sl)	2015-09-30	Gensko modificirana celica in postopek za uporabo omenjene celice
IL237527A0 (en)	2015-04-30	Devices and methods for growing cells
SG2014011282A (en)	2014-06-27	Anode battery materials and methods of making the same
PT3527584T (pt)	2021-01-04	Recetores de célula t anti-ny-eso-1 murinos
IL228031A0 (en)	2013-09-30	Adno vectors for gene therapy in choroideremia
EP2721019A4 (en)	2014-11-19	THERAPEUTIC ACTIVE COMPOSITIONS AND METHOD FOR THEIR USE
PL2683731T3 (pl)	2019-09-30	C4-monometylowe pochodne triterpenoidów i sposoby ich zastosowania
SG2014013676A (en)	2014-05-29	Therapeutics using adipose cells and cell secretions
SI3321355T1 (sl)	2021-11-30	Postopki in sestavki za klinično izpeljavo alogenske celice in terapevtske uporabe
GB201100180D0 (en)	2011-02-23	Tumour cell and tissue culture
EP2606123A4 (en)	2014-01-15	METHOD OF GENERATING OLIGOD DROCYTES AND CELL POPULATIONS THEREWITH
EP2555801A4 (en)	2014-02-26	SELECTION AND USE OF HOST CELLS FOR THE MANUFACTURE OF GLYCOPROTEINS
IL226666B (en)	2018-10-31	Methods of generating corneal cells and cell populations comprising same
GB201200458D0 (en)	2012-02-22	Methods of preparing cells and compositions
IL228708A0 (en)	2013-12-31	Analogues of epoxyeicostrienoic acid and methods for their preparation and use
SG11201502497RA (en)	2015-04-29	Sebocyte cell culturing and methods of use
EP2616073A4 (en)	2015-02-18	INHIBITORS OF IMMERSION OF VIRUSES IN MAMMALIAN HOST CELLS
SG11201401038VA (en)	2014-07-30	Isolating and therapeutic use of perivascular medicinal cells
SG11201406771PA (en)	2014-11-27	Stem cell preparations and methods of use
TWM401215U (en)	2011-04-01	Parallel structure of battery and battery set having the structure
BR112014014033A2 (pt)	2017-07-11	células pulmonares fetais de mamíferos e uso terapêutico das mesmas
ZA201308320B (en)	2015-01-28	Epoxyeicosatrienoic acid analogs and methods of making and using the same